Literature DB >> 3685351

Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation.

N L Müller1, C A Staples, R R Miller, S Vedal, W M Thurlbeck, D N Ostrow.   

Abstract

Computed tomography (CT) scans were compared with pathologic determinants of disease activity in 12 patients with idiopathic pulmonary fibrosis. The theory was that intraalveolar and interstitial cellularity would result in areas of opacification of air spaces on CT scans. All patients underwent open lung biopsy, and disease activity was assessed with a pathologic grading system. Seven patients had mild disease activity, five had moderate to marked disease activity. Opacification of air spaces was patchy in distribution, predominantly peripheral, and seen better on 1.5-mm rather than 10-mm collimation scans. Disease activity on CT scans was graded independently from 0 to 3 based on the presence and relative density of the areas of air space consolidation compared with the surrounding parenchyma. The pathologic score was significantly greater in the patients with high CT scores than in those with low CT scores (P = .001). Five patients with marked disease activity and five of seven patients with mild disease activity were correctly identified. CT may be useful in the assessment of disease activity in idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Year:  1987        PMID: 3685351     DOI: 10.1148/radiology.165.3.3685351

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  29 in total

Review 1.  Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Authors:  A Wells
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  High resolution computed tomography as a predictor of lung histology in systemic sclerosis.

Authors:  A U Wells; D M Hansell; B Corrin; N K Harrison; P Goldstraw; C M Black; R M du Bois
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

Review 4.  The role of high resolution computed tomography in the diagnosis of interstitial lung disease.

Authors:  D M Hansell; I H Kerr
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

Review 5.  Why is high resolution computerized tomography scanning used in evaluating the lungs?

Authors:  W A Graves; J D Collins; T Q Miller
Journal:  J Natl Med Assoc       Date:  1989-10       Impact factor: 1.798

6.  Electrocardiography-triggered high-resolution CT for reducing cardiac motion artifact: evaluation of the extent of ground-glass attenuation in patients with idiopathic pulmonary fibrosis.

Authors:  Motoko Nishiura; Takeshi Johkoh; Shuji Yamamoto; Osamu Honda; Takenori Kozuka; Mitsuhiro Koyama; Noriyuki Tomiyama; Seiki Hamada; Takamichi Murakami; Takashi Matsumoto; Yoshifumi Narumi; Hironobu Nakamura
Journal:  Radiat Med       Date:  2007-12-25

Review 7.  [Identification of lung architecture using HRCT].

Authors:  M Reuter; J Biederer
Journal:  Radiologe       Date:  2009-02       Impact factor: 0.635

8.  Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis.

Authors:  J Biederer; A Schnabel; C Muhle; W L Gross; M Heller; M Reuter
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

9.  Correlation between pulmonary fibrosis and the lung pressure-volume curve.

Authors:  R H Sansores; A Ramirez-Venegas; R Pérez-Padilla; M Montaño; C Ramos; C Becerril; M Gaxiola; P Paré; M Selman
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  CT analysis of the anterior mediastinum in idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

Authors:  Chang Hyun Lee; Hyun Ju Lee; Kyu Ri Son; Eun Ju Chun; Kun Young Lim; Jin Mo Goo; Jung-Gi Im; Jeong Nam Heo; Jae-Woo Song
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.